Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M700194200 on June 11, 2007

J. Biol. Chem., Vol. 282, Issue 32, 23337-23347, August 10, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/32/23337    most recent
M700194200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeisberg, M.
Right arrow Articles by Kalluri, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeisberg, M.
Right arrow Articles by Kalluri, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition*

Michael Zeisberg{ddagger}12, Changqing Yang{ddagger}13, Margot Martino{ddagger}, Michael B. Duncan{ddagger}4, Florian Rieder{ddagger}, Harikrishna Tanjore{ddagger}, and Raghu Kalluri{ddagger}§5

From the {ddagger}Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachussetts 02215, the §Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02215, and the Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts 02215

Activated fibroblasts are key contributors to the fibrotic extracellular matrix accumulation during liver fibrosis. The origin of such fibroblasts is still debated, although several studies point to stellate cells as the principal source. The role of adult hepatocytes as contributors to the accumulation of fibroblasts in the fibrotic liver is yet undetermined. Here, we provide evidence that the pro-fibrotic growth factor, TGF-beta1, induces adult mouse hepatocytes to undergo phenotypic and functional changes typical of epithelial to mesenchymal transition (EMT). We perform lineage-tracing experiments using AlbCre. R26RstoplacZ double transgenic mice to demonstrate that hepatocytes which undergo EMT contribute substantially to the population of FSP1-positive fibroblasts in CCL4-induced liver fibrosis. Furthermore, we demonstrate that bone morphogenic protein-7 (BMP7), a member of the TGFbeta superfamily, which is known to antagonize TGFbeta signaling, significantly inhibits progression of liver fibrosis in these mice. BMP7 treatment abolishes EMT-derived fibroblasts, suggesting that the therapeutic effect of BMP7 was at least partially due to the inhibition of EMT. These results provide direct evidence for the functional involvement of adult hepatocytes in the accumulation of activated fibroblasts in the fibrotic liver. Furthermore, our findings suggest that EMT is a promising therapeutic target for the attenuation of liver fibrosis.


Received for publication, January 8, 2007 , and in revised form, June 6, 2007.

* This study was funded in part by the Espinosa Fibrosis Fund, a research grant from the Johnson & Johnson Companies, Research Grants DK62987, DK55001, DK61688, and AI53194 (to R. K.) from the National Institutes of Health, and a research fund from the Beth Israel Deaconess Medical Center for the Division of Matrix Biology. The first evidence for EMT involving adult primary hepatocytes was first reported by our laboratory at the 2003 Digestive Disease Week (DDW) meeting in Orlando, Florida. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this report.

2 Funded by Grant 5K08DK074558-01 from the National Institutes of Health and the ASN Carl W. Gottschalk Award 2006.

3 Funded by a postdoctoral fellowship derived from the Espinosa Fibrosis Fund and BIDMC Liver Center.

4 Funded by National Institutes of Health Grant DK055001-07S1.

5 To whom correspondence should be addressed: Dept. of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave., RW514, Boston, MA 02215. Tel.: 617-667-0445; Fax: 617-975-5663; E-mail: rkalluri{at}bidmc.harvard.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. Ponticos, C. Harvey, T. Ikeda, D. Abraham, and G. Bou-Gharios
JunB mediates enhancer/promoter activity of COL1A2 following TGF-{beta} induction
Nucleic Acids Res., June 26, 2009; (2009) gkp544v1.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. L. Worthley, A. Ruszkiewicz, R. Davies, S. Moore, I. Nivison-Smith, L. Bik To, P. Browett, R. Western, S. Durrant, J. So, et al.
Human Gastrointestinal Neoplasia-Associated Myofibroblasts Can Develop from Bone Marrow-Derived Cells Following Allogeneic Stem Cell Transplantation
Stem Cells, June 1, 2009; 27(6): 1463 - 1468.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. V. Fedorova, V. Raju, N. El-Okdi, A. Shidyak, D. J. Kennedy, S. Vetteth, D. R. Giovannucci, A. Y. Bagrov, O. V. Fedorova, J. I. Shapiro, et al.
The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F922 - F934.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
G. Maubach, M. C. C. Lim, and L. Zhuo
Nuclear Cathepsin F Regulates Activation Markers in Rat Hepatic Stellate Cells
Mol. Biol. Cell, October 1, 2008; 19(10): 4238 - 4248.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Strutz
The great escape--myofibroblasts in fibrosis and the immune system
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2477 - 2479.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Lavery, P. Swain, D. Falb, and M. H. Alaoui-Ismaili
BMP-2/4 and BMP-6/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells
J. Biol. Chem., July 25, 2008; 283(30): 20948 - 20958.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Piper Hanley, F. Oakley, S. Sugden, D. I. Wilson, D. A. Mann, and N. A. Hanley
Ectopic SOX9 Mediates Extracellular Matrix Deposition Characteristic of Organ Fibrosis
J. Biol. Chem., May 16, 2008; 283(20): 14063 - 14071.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
T. Kisseleva and D. A. Brenner
Fibrogenesis of Parenchymal Organs
Proceedings of the ATS, April 15, 2008; 5(3): 338 - 342.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Myllarniemi, P. Lindholm, M. J. Ryynanen, C. R. Kliment, K. Salmenkivi, J. Keski-Oja, V. L. Kinnula, T. D. Oury, and K. Koli
Gremlin-mediated Decrease in Bone Morphogenetic Protein Signaling Promotes Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 321 - 329.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement